BAMCO Inc Portfolio holdings
AUM
$36.9B
1-Year Return
31.2%
This Quarter Return
+11.92%
1 Year Return
+31.2%
3 Year Return
+112.46%
5 Year Return
+202.3%
10 Year Return
+748.08%
AUM
$26.2B
AUM Growth
+$1.88B
(+7.7%)
Cap. Flow
-$524M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
380
New
30
Increased
107
Reduced
146
Closed
27
Top Buys
| 1 |
BWIN
Baldwin Insurance Group
BWIN
|
$41.6M |
| 2 |
GDS Holdings
GDS
|
$32.9M |
| 3 |
Globant
GLOB
|
$30.1M |
| 4 |
XP
XP
|
$27M |
| 5 |
NFH
New Frontier Health Corporation Ordinary Shares
NFH
|
$25.4M |
Top Sells
| 1 |
CoStar Group
CSGP
|
$73.9M |
| 2 |
Vail Resorts
MTN
|
$62.9M |
| 3 |
CISN
Cision Ltd. Ordinary Share
CISN
|
$46.1M |
| 4 |
Expedia Group
EXPE
|
$41.7M |
| 5 |
Idexx Laboratories
IDXX
|
$34.7M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 20.32% |
| 3 | Financials | 16.92% |
| 4 | Healthcare | 13.17% |
| 5 | Real Estate | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Zimmer Biomet
ZBH
$20.9B
| $539K | ﹤0.01% |
3,708
+1,133
| +44% | +$165K |
|
302
Humana
HUM
$37.4B
| $495K | ﹤0.01% |
1,350
+300
| +29% | +$110K |
|
303
Apple
AAPL
$3.56T
| $418K | ﹤0.01% |
5,696
-352
| -6% | -$25.8K |
|
304
Accenture
ACN
$158B
| $411K | ﹤0.01% |
1,950
+548
| +39% | +$116K |
|
305
Moody's
MCO
$88.9B
| $393K | ﹤0.01% |
1,655
+58
| +4% | +$13.8K |
|
|
INFO
306
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $392K | ﹤0.01% |
5,202
| – | – |
|
307
Qualcomm
QCOM
$173B
| $353K | ﹤0.01% |
4,000
| – | – |
|
308
Berkshire Hathaway Class A
BRK.A
$1.08T
| $340K | ﹤0.01% |
1
| – | – |
|
309
Danaher
DHR
$144B
| $337K | ﹤0.01% |
2,475
+186
| +8% | +$25.3K |
|
310
HCA Healthcare
HCA
$97.2B
| $308K | ﹤0.01% |
2,085
| – | – |
|
311
Insulet
PODD
$24.4B
| $288K | ﹤0.01% |
1,685
-327
| -16% | -$55.9K |
|
312
Constellation Brands
STZ
$26.3B
| $275K | ﹤0.01% |
1,448
| – | – |
|
313
Walt Disney
DIS
$213B
| $241K | ﹤0.01% |
1,667
+1,102
| +195% | +$159K |
|
|
BHVN
314
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $234K | ﹤0.01% |
+4,300
| New | +$234K |
|
315
Procter & Gamble
PG
$376B
| $224K | ﹤0.01% |
1,796
| – | – |
|
316
Alcon
ALC
$39.7B
| $219K | ﹤0.01% |
3,879
-1,200
| -24% | -$67.7K |
|
317
Goldman Sachs
GS
$222B
| $184K | ﹤0.01% |
800
| – | – |
|
318
Brookfield Infrastructure Partners
BIP
$14.1B
| $171K | ﹤0.01% |
5,747
+615
| +12% | +$18.3K |
|
319
TE Connectivity
TEL
$61.3B
| $171K | ﹤0.01% |
1,786
-67
| -4% | -$6.42K |
|
320
Charter Communications
CHTR
$35.7B
| $166K | ﹤0.01% |
343
| – | – |
|
321
Blackrock
BLK
$170B
| $165K | ﹤0.01% |
328
-87
| -21% | -$43.8K |
|
322
Zoetis
ZTS
$68.1B
| $159K | ﹤0.01% |
+1,200
| New | +$159K |
|
323
PTC Therapeutics
PTCT
$4.62B
| $157K | ﹤0.01% |
+3,275
| New | +$157K |
|
324
Paylocity
PCTY
$9.77B
| $147K | ﹤0.01% |
+1,218
| New | +$147K |
|
325
Texas Instruments
TXN
$170B
| $146K | ﹤0.01% |
1,139
| – | – |
|